Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artificial Intelligence
MedTech
FDA clears Clairity's 5-year breast cancer risk prediction tool
The FDA’s de novo clearance paves the way for Clairity to launch the risk prediction platform with leading health systems through 2025.
Heather Landi
Jun 5, 2025 1:00pm
FDA launces generative AI tool Elsa a month ahead of schedule
Jun 3, 2025 10:40am
BioNTech makes £1B commitment to expand UK research, build HQ
May 20, 2025 11:15am
Revised Blueprint-VantAI deal turns focus to molecular glues
May 20, 2025 10:32am
Pathos AI's $365M series D to fund trial of Novo tumor drug
May 15, 2025 10:20am
Philips survey shows gaps in patient, provider trust in AI
May 15, 2025 6:00am
